Future concepts in bronchodilation for COPD: dual- versus monotherapy

por Singh, Dave, Donohue, James F., Boucot, Isabelle H., Barnes, Neil C., Compton, Chris, Martinez, Fernando J.
Publicado 2021

Effect of Age on Efficacy and Safety of Fluticasone Furoate/Vilanterol (FF/VI), Umeclidinium (UMEC), and UMEC + FF/VI in Patients with Chronic Obstructive Pulmonary Disease: Analys...

por Hanania, Nicola A, Caveney, Scott, Soule, Tedi, Tombs, Lee, Lettis, Sally, Crim, Courtney, Mannino, David M, Patel, Hitesh, Boucot, Isabelle H
Publicado 2021

Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD: A Prespecified Analysis of The EMAX Trial

por Bjermer, Leif H., Boucot, Isabelle H., Vogelmeier, Claus F., Maltais, François, Jones, Paul W., Tombs, Lee, Compton, Chris, Lipson, David A., Kerwin, Edward M.
Publicado 2021

Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening: a post hoc analysis of the EMAX trial

por Vogelmeier, Claus F., Jones, Paul W., Kerwin, Edward M., Boucot, Isabelle H., Maltais, François, Tombs, Lee, Compton, Chris, Lipson, David A., Bjermer, Leif H.
Publicado 2021

Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial

por Kerwin, Edward M, Boucot, Isabelle H, Vogelmeier, Claus F, Maltais, Francois, Naya, Ian P, Tombs, Lee, Jones, Paul W, Lipson, David A, Keeley, Tom, Bjermer, Leif
Publicado 2020

Treatment of COPD with Long-Acting Bronchodilators: Association Between Early and Longer-Term Clinically Important Improvement

por Vogelmeier, Claus F, Naya, Ian P, Maltais, François, Bjermer, Leif, Kerwin, Edward M, Tombs, Lee, Jones, Paul W, Compton, Chris, Lipson, David A, Boucot, Isabelle H
Publicado 2021

Dual Bronchodilator Therapy as First-Line Treatment in Maintenance-Naïve Patients with Symptomatic COPD: A Pre-Specified Analysis of the EMAX Trial

por Bjermer, Leif, Boucot, Isabelle H, Maltais, François, Kerwin, Edward M, Naya, Ian P, Tombs, Lee, Jones, Paul W, Compton, Chris, Lipson, David A, Vogelmeier, Claus F
Publicado 2021

Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trial

por Vogelmeier, Claus F., Kerwin, Edward M., Bjermer, Leif H., Tombs, Lee, Jones, Paul W., Boucot, Isabelle H., Naya, Ian P., Lipson, David A., Compton, Chris, Barnes, Neil, Maltais, François
Publicado 2020

Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised tr...

por Maltais, François, Bjermer, Leif, Kerwin, Edward M., Jones, Paul W., Watkins, Michael L., Tombs, Lee, Naya, Ian P., Boucot, Isabelle H., Lipson, David A., Compton, Chris, Vahdati-Bolouri, Mitra, Vogelmeier, Claus F.
Publicado 2019